3sbio

company

About

3SBio is a fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing.

  • Shenyang,Liaoning,China
  • 501 - 1000

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
Fr15M
Industries
Biotechnology
Founded date
Jan 1, 1993
Number Of Employee
501 - 1000
Operating Status
Active
Stock Symbol
hkg:1530
Legal Name
Sunshine Guojian Pharmaceuticals (Shanghai) Co., Ltd.

3SBio is a fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
Fr15M
3sbio has raised a total of Fr15M in funding over 2 rounds. Their latest funding was raised on Dec 12, 2019 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 12, 2019 Post-IPO Equity Fr15M 1 Numab Detail
Jun 12, 2015 IPO Detail

Investments

Number of Investments
Number of Lead Investments
4
1
3sbio has made 4 investments. Their most recent investment was on Dec 20, 2019, when GenSight Biologics raised €15M.
Date Company Name
Round Money Raised Industry Lead Investor
Post-IPO Debt €15M Biotechnology
Dec 12, 2019 Numab
Series B Fr22M Biopharma
Series Unknown $50M Biotechnology
Series B $25M Biotechnology Yes

Investors

Number of Lead Investors
Number of Investors
1
1
3sbio is funded by 1 investors. Numab are the most recent investors.
Investor Name Lead Investor Funding Round
Numab Yes Post-IPO Equity

Employee Profiles

Number of Employee Profiles
3
3sbio has 3 current employee profiles, including Executive Dr. Jing Lou
Executive
Board member
Board member

Exits

3sbio has had 1 exits. 3sbio most notable exits include GenSight Biologics

Date Company Name Exit Type Industry
Jul 15, 2016 GenSight Biologics IPO Biotechnology Detail

Acquisition

3sbio has acquired 3 organizations. Their most recent acquisition was Sirton Pharmaceuticals on Jan 26, 2015. They acquired Sirton Pharmaceuticals for 0.

Date Company Name
Industry Acquisition Type Price
Manufacturing acquisition Detail
Biotechnology acquisition $ 85M Detail
Manufacturing acquisition $ 290M Detail